Populations for CRT devices

Heart Rhythm

Volumn 6, Issue 9, 2009, Pages 1373-1377

  Ujeyl, Amaar ^a   Stevenson, Lynne Warner ^b  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiac resynchronization therapy; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; DOXORUBICIN; TRASTUZUMAB;

AGE DISTRIBUTION; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL; SYSTOLIC BLOOD PRESSURE; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT RESPONSE; DEVICES; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART STROKE VOLUME; PREVALENCE; PROGNOSIS; RISK FACTOR; UNITED STATES;

CARDIAC PACING, ARTIFICIAL; DISEASE PROGRESSION; EQUIPMENT AND SUPPLIES; HEART FAILURE; HUMANS; PREVALENCE; PROGNOSIS; RISK FACTORS; STROKE VOLUME; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 68949200812     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.04.011     Document Type: Article

References (14)

1. Fonarow G.C. Epidemiology and risk stratification in acute heart failure. JAMA 293 (2005) 572-580
2. Young J.B., Abraham W.T., Smith A.L., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 289 (2003) 2685-2694
3. Bristow M.R., Feldman A.M., and Saxon L.A. Heart failure management using implantable devices for intraventricular resynchronization: comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 6 (2000) 276-285
4. Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
5. Linde C., Abraham W.T., Gold M.R., Sutton M.S., Ghio S., and Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52 (2008) 1834-1843
6. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm 5 (2008) 934-955
7. Bleeker G.P., Kaandorp T.A.M., Lamb H.J., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113 (2006) 969-976
8. Carson P., Anand I., O'Connor C., et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 46 (2005) 2329-2334
9. Bardy G.H., Lee K.L., Mark D.B., et al., The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
10. Goldenberg I., Vyas A.K., Hall W.J., et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51 (2008) 288-296
11. Lindenfeld J., Feldman A.M., Saxon L., et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115 (2007) 204-212
12. Swedberg K., Cleland J., Cowie M.R., et al. Successful treatment of heart failure devices requires collaboration. Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail 10 (2008) 1229-1236
13. Setoguchi S., Nohria A., Rassen J., Stevenson L.W., and Schneeweiss S. Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure. CMAJ 180 (2009) 611-616
14. Hammill S.C., Kremers M.S., Stevenson L.W., et al. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 5 (2008) 1359-1363